TrialInternational journal of radiation oncology, biology, physics2011

Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074.

Joon H Uhm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.